|
| Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes |
|
https://doi.org/10.18632/oncotarget.27135
Cestmir Altaner, Ursula Altanerova, Jana Jakubechova
|
| 5573-5575 |
|
| Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone |
|
https://doi.org/10.18632/oncotarget.27159
Balaji Krishnamachary, Dharmalingam Subramaniam, Prasad Dandawate, Sivapriya Ponnurangam, Pugazhendhi Srinivasan, Prabhu Ramamoorthy, Shahid Umar, Sufi Mary Thomas, Animesh Dhar, Seth Septer, Scott J. Weir, Thomas Attard, Shrikant Anant
|
| 5576-5591 |
|
| Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.27172
Yuzan Kudo, Shiro Kohi, Keiji Hirata, Michael Goggins, Norihiro Sato
|
| 5592-5604 |
|
| Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial |
|
https://doi.org/10.18632/oncotarget.27188
Rajnish Nagarkar, Darshana Patil, Timothy Crook, Vineet Datta, Sagar Bhalerao, Sonal Dhande, Vijay Palwe, Shirsendu Roy, Prakash Pandit, Ashwini Ghaisas, Raymond Page, Harjeetsingh Kathuria, Ajay Srinivasan, Dadasaheb Akolkar
|
| 5605-5621 |
|
| Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosomes has antineoplastic effects for gallbladder cancer |
|
https://doi.org/10.18632/oncotarget.27193
Hidehiko Hishikawa, Masaki Kaibori, Takumi Tsuda, Kosuke Matsui, Tadayoshi Okumura, Eiichi Ozeki, Kengo Yoshii
|
| 5622-5631 |
|
| Impact of exosomal HIV-1 Tat expression on the human cellular proteome |
|
https://doi.org/10.18632/oncotarget.27207
Huafei Lu, Xiaoli Tang, Mitchell Sibley, Jillian Coburn, R. Shyama Prasad Rao, Nagib Ahsan, Bharat Ramratnam
|
| 5632-5644 |
|
| Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.27210
Kwang Woon Kim, Julia Y. Kim, Jingbo Qiao, Rachael A. Clark, Camille M. Powers, Hernan Correa, Dai H. Chung
|
| 5645-5659 |
|
| Stereotactic body radiation therapy for prostate cancer: systematic review and meta-analysis of prospective trials |
|
https://doi.org/10.18632/oncotarget.27177
Taylor R. Cushman, Vivek Verma, Rahul Khairnar, Joseph Levy, Charles B. Simone 2nd, Mark V. Mishra
|
| 5660-5668 |
|
| Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine |
|
https://doi.org/10.18632/oncotarget.27216
Deok-Beom Jung, Miyong Yun, Eun-Ok Kim, Jaekwang Kim, Bonglee Kim, Ji Hoon Jung, Enfeng Wang, Debabrata Mukhopadhyay, Edward Hammond, Keith Dredge, Viji Shridhar, Sung-Hoon Kim
|
| 5669-5669 |
|
| Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development |
|
https://doi.org/10.18632/oncotarget.27218
Laura Molina, Hong Yang, Adeola O. Adebayo Michael, Michael Oertel, Aaron Bell, Sucha Singh, Xin Chen, Junyan Tao, Satdarshan P. Monga
|
| 5670-5670 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
